查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538917

按類型、性別和服務供應商皮膚填充劑市場：2024-2033 年全球機會分析和產業預測

Dermal Filler Market By Type (Hyaluronic acid , Calcium Hydroxylapatite , Poly L lactic Acid, Others), By Gender By Service Provider : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2021年全球皮膚填充劑市場價值為51.848億美元，預計到2031年將達到144.184億美元，2022年至2031年的複合年成長率為10.8%。

皮膚填充劑被定義為注射到皮膚表面下方以增加豐滿度和體積、撫平細紋、軟化皺紋並增強臉部輪廓的美容手術。廣泛用於臉部美容療程。皮膚填充劑的類型包括透明質酸、羥基羥磷石灰、聚乳酸和聚甲基丙烯酸甲酯微球。這用於增強或填充臉部的淺層區域。此手術也常用於改善眼部皺紋。

真皮填充劑市場-IMG1

全球皮膚填充劑市場的成長主要是由於微創手術需求的顯著成長、政府為推進皮膚填充劑手術而採取的舉措不斷增加、皮膚填充劑產品的核准數量迅速增加以及透明質酸的採用不斷增加。根據《皮膚病學與莫氏外科研究所日誌》報導，皮膚填充劑被分析為全球領先的微創皮膚手術之一。例如，2021年，領先的專業服務公司之一德勤報告稱，中國消耗了約9.53%的透明質酸。因此，透明質酸的日益普及將推動對皮膚填充劑手術的需求。

此外，2021 年，美國食品藥物管理局(FDA) 宣布批准 RHA 真皮填充劑用於治療 22 歲及以上成年人的中度至重度動態口周皺襞（唇紋）。此外，生技公司 Revance Therapeutics, Inc. 於 2021 年發布了有關其 RHA皮膚填充劑系列的功效和安全性資料。這是透明質酸填充劑技術的最新進展之一，用於治療深色膚色的中度至重度法令紋。皮膚填充劑技術的不斷進步旨在實現持久有效的效果。因此，新興國家先進皮膚填充劑產品的技術進步預計將推動市場成長。

政府對整容手術的支持不斷增加以及整容手術需求的激增是推動全球皮膚填充劑市場的主要因素。例如，2022年2月，英國政府宣布將為皮膚填充劑和肉毒桿菌等非手術整容手術引入許可製度。這項措施旨在保護公眾免受假冒填充劑和肉毒桿菌的侵害。此外，抗衰老治療的興起對市場成長做出了重大貢獻。年輕人對外觀美學需求的不斷成長是全球市場擴張的主要動力。

然而，與皮膚填充劑手術相關的高成本預計將阻礙市場成長。皮膚過早老化現象的日益普遍，導致對透明質酸的需求急劇增加，推動了市場的成長。這進一步鼓勵了許多主要參與者進入新興市場，為皮膚填充劑市場提供了利潤豐厚的成長機會。

皮膚填充劑市場按類型、性別、服務供應商和地區細分。依類型分類，市場分為透明質酸（HA）、羥基磷灰石鈣（CaHA）、聚左旋乳酸等。另一部分則進一步分為聚甲基丙烯酸甲酯微球（PMMA）和脂肪組織。從性別上來說，分為男性和女性。依服務提供者分類，可分為專科/皮膚科診所、醫院等。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

相關人員的主要利益

  • 該報告提供了 2021 年至 2031 年皮膚填充劑市場分析的細分市場、當前趨勢、估計和動態的定量分析，並確定了一般皮膚填充劑市場機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析揭示了買家和供應商的潛力，幫助相關人員做出利潤驅動的業務決策並加強供應商和買家網路。
  • 皮膚填充劑市場區隔的詳細分析有助於識別市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前位置的清晰了解。
  • 該報告包括對區域和全球皮膚填充劑市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • COVID-19 市場影響分析
  • 專利情況

第4章皮膚填充劑市場：依類型

  • 概述
  • 透明質酸（HA）
    • 透明質酸（HA）皮膚填充劑市場，依年齡層分類
  • 羥基磷灰石鈣 (CaHA)
  • 聚乳酸
  • 其他

第5章皮膚填充劑市場：依性別

  • 概述
  • 男性
  • 女士

第6章皮膚填充劑市場：依服務供應商

  • 概述
  • 專科和皮膚科診所
  • 醫院
  • 其他

第7章皮膚填充劑市場：依地區

  • 概述
  • 北美洲
    • 北美透明質酸 (HA)皮膚填充劑市場：依年齡層別
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲透明質酸 (HA)皮膚填充劑市場：依年齡層別
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太地區透明質酸 (HA)皮膚填充劑市場：依年齡層別
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 拉丁美洲/中東/非洲
    • 拉丁美洲、中東和非洲的透明質酸 (HA)皮膚填充劑市場：按年齡分類
    • 巴西
    • 沙烏地阿拉伯
    • 哥倫比亞
    • 其他

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2021年）

第9章 公司簡介

  • AbbVie Laboratories
  • Bioxis pharmaceutical
  • Cutera Inc
  • Elan aesthetics Inc
  • Galderma SA
  • Merz Pharma GmbH and Co. KGaA
  • Revance Therapeutics
  • Sinclair Pharma
  • Teoxane Laboratories
  • Vital Esthetique Laboratories
簡介目錄
Product Code: A07289

The global dermal filler market was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as an aesthetic procedure, which is injected beneath the surface of the skin to add fullness & volume, smooth lines & soften creases, and increase the facial contours. It is widely used for facial aesthetic treatment. The different types of dermal filler are hyaluronic acid, calcium hydroxylapatite, polylactic acid, and polymethyl-methacrylate microspheres. It is used to enhance or fill the shallow areas on the face. In addition, this procedure is mostly used among population to reduce wrinkle under eyes.

Dermal Filler Market - IMG1

The growth of the global dermal filler market is majorly driven by an alarming increase in demand for minimally invasive procedure; rise in government initiative for the advancement of dermal filler procedure; surge in the number of approvals for dermal filler' products; and a rise in adoption of hyaluronic acid. According to the journal of Dermatology & Mohs Surgery Institute, it was analyzed that dermal filler is one of the leading minimally invasive skin procedure, globally. For instance, in 2021, Deloitte, one of the leading professional services companies, reported that around 9.53% of hyaluronic acid is consumed in China. Thus, the increase in prevalence of hyaluronic acid boosts the demand for dermal filler procedure.

Moreover, in 2021, the U.S. Food and drug Administration (FDA) announced the approval of RHA Redensity Dermal Filler, which is used for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in the adults above the age of 22. Furthermore, in 2021, Revance Therapeutics, Inc., a biotechnology company, presented data on the effectiveness and safety of the RHA collection of dermal filler. It is one of the latest advances in hyaluronic acid filler technology, which is used for the treatment of moderate-to-severe nasolabial folds in darker skin color. The increase in advancements in dermal filler technology aims to obtain long-lasting, and effective results. Thus, advancements in technology for advanced dermal filler products in emerging nations are expected to propel the growth of the market.

The increase in government support for aesthetic procedure and surge in demand for aesthetic procedure are the major factors that drive the global dermal filler market. For instance, in February 2022, the GOV.UK announced to introduce a licensing regime for non-surgical cosmetic procedures such as dermal filler and Botox. This step aims to protect the public against botch fillers and botox. In addition, increase in the number of anti-aging treatment significantly contributes toward the market growth. Rise in demand for aesthetic looks among young population acts a key driving force for the expansion of the global market.

However, the high cost associated with dermal filler procedure is anticipated to hinder the market growth. Increase in prevalence of early skin aging, surge the need for hyaluronic acid and drive the growth of the market. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the dermal filler market.

The dermal filler market is segmented into type, gender, service provider, and region. By type, the market is categorized into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. By gender, it is bifurcated into male and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global dermal filler market are include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermal filler market analysis from 2021 to 2031 to identify the prevailing dermal filler market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the dermal filler market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global dermal filler market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Key Market Segments

By Type

  • Hyaluronic acid (HA)
    • Age group

◦ 13 to 39

◦ 40 to 54

◦ 55 to 69

  • Calcium Hydroxylapatite (CaHA)
  • Poly L lactic Acid
  • Others

By Gender

  • Male
  • Female

By Service Provider

  • Specialty and Dermatology Clinics
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Teoxane Laboratories
    • Cutera Inc
    • Elan aesthetics Inc
    • Bioxis pharmaceutical
    • AbbVie Laboratories
    • Sinclair Pharma
    • Sosum Global
    • Revance Therapeutics
    • Galderma SA
    • Merz Pharma

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. COVID-19 Impact Analysis on the market
  • 3.6. Patent Landscape

CHAPTER 4: DERMAL FILLER MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Hyaluronic acid (HA)
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Hyaluronic acid (HA) Dermal Filler Market by Age group
      • 4.2.4.1. 13 to 39 Market size and forecast, by region
      • 4.2.4.2. 40 to 54 Market size and forecast, by region
      • 4.2.4.3. 55 to 69 Market size and forecast, by region
  • 4.3. Calcium Hydroxylapatite (CaHA)
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Poly L lactic Acid
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: DERMAL FILLER MARKET, BY GENDER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Male
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Female
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Specialty and Dermatology Clinics
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Hospitals
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: DERMAL FILLER MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
      • 7.2.2.1. North America Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.2.3. Market size and forecast, by Gender
    • 7.2.4. Market size and forecast, by Service Provider
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Gender
      • 7.2.5.1.4. Market size and forecast, by Service Provider
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Gender
      • 7.2.5.2.4. Market size and forecast, by Service Provider
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Gender
      • 7.2.5.3.4. Market size and forecast, by Service Provider
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
      • 7.3.2.1. Europe Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.3.3. Market size and forecast, by Gender
    • 7.3.4. Market size and forecast, by Service Provider
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Gender
      • 7.3.5.1.4. Market size and forecast, by Service Provider
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Gender
      • 7.3.5.2.4. Market size and forecast, by Service Provider
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Gender
      • 7.3.5.3.4. Market size and forecast, by Service Provider
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Gender
      • 7.3.5.4.4. Market size and forecast, by Service Provider
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Gender
      • 7.3.5.5.4. Market size and forecast, by Service Provider
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Gender
      • 7.3.5.6.4. Market size and forecast, by Service Provider
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
      • 7.4.2.1. Asia-Pacific Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.4.3. Market size and forecast, by Gender
    • 7.4.4. Market size and forecast, by Service Provider
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Gender
      • 7.4.5.1.4. Market size and forecast, by Service Provider
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Gender
      • 7.4.5.2.4. Market size and forecast, by Service Provider
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Gender
      • 7.4.5.3.4. Market size and forecast, by Service Provider
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Gender
      • 7.4.5.4.4. Market size and forecast, by Service Provider
      • 7.4.5.5. Rest of Asia-Pacific
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Gender
      • 7.4.5.5.4. Market size and forecast, by Service Provider
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
      • 7.5.2.1. LAMEA Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.5.3. Market size and forecast, by Gender
    • 7.5.4. Market size and forecast, by Service Provider
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Gender
      • 7.5.5.1.4. Market size and forecast, by Service Provider
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Gender
      • 7.5.5.2.4. Market size and forecast, by Service Provider
      • 7.5.5.3. Colombia
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Gender
      • 7.5.5.3.4. Market size and forecast, by Service Provider
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Gender
      • 7.5.5.4.4. Market size and forecast, by Service Provider

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. AbbVie Laboratories
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
  • 9.2. Bioxis pharmaceutical
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
  • 9.3. Cutera Inc
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
  • 9.4. Elan aesthetics Inc
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
  • 9.5. Galderma SA
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
  • 9.6. Merz Pharma GmbH and Co. KGaA
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
  • 9.7. Revance Therapeutics
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
  • 9.8. Sinclair Pharma
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
  • 9.9. Teoxane Laboratories
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
  • 9.10. Vital Esthetique Laboratories
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot